Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Recruiting

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Sponsor:

NYU Langone Health

Code:

NCT05641753

Conditions

Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Evolocumab Cartridge

Atorvastatin Calcium Tablets

Ezetimibe Tablets

18F-FDG

Angiocatheter 20IV

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2025-03-03.